Expression of CD24 on CD19- CD79a+ early B-cell progenitors in human bone marrow

Area of Science:

• Immunology
• Hematology
• Cell Biology

Background:

• CD24 (Cluster of Differentiation 24) is a known surface marker on B cells, implicated in cellular adhesion and apoptosis.
• The precise stage of early human B-cell development when CD24 expression begins remains undefined.
• Understanding B-cell progenitor markers is crucial for diagnosing and treating hematological malignancies.

Purpose of the Study:

• To determine the earliest stage of human B-cell development characterized by CD24 expression.
• To investigate the relationship between CD24 and CD19 expression during lymphopoiesis.
• To identify early B-cell progenitor populations in human bone marrow.

Main Methods:

• Analysis of lymphopoiesis in normal pediatric bone marrow (BM) using flow cytometry.
• Characterization of CD24+ lymphocytes lacking CD19 expression (CD19- CD24+).
• Assessment of co-expression of other lineage and progenitor markers (CD45, CD10, CD34, CD79a, CD179a, TdT).

Main Results:

• A small population of CD24+ lymphocytes, negative for CD19 and expressing low CD45 (CD19- CD24+ CD45low), was identified in normal pediatric BM.
• These CD19- CD24+ CD45low cells exhibited characteristics of early B-cell progenitors, expressing CD10, CD34, CD79a, CD179a (VpreB), and TdT.
• Similar cell populations were found in regenerating BM of children post-chemotherapy for acute lymphoblastic leukemia and in normal adult BM.

Conclusions:

• CD24 is expressed on CD19- negative early B-cell progenitors in human bone marrow.
• The expression of CD24 precedes the expression of CD19 during human B-cell development.
• This finding provides a new marker for identifying the earliest stages of B-cell lineage commitment.